| |
| Issue |
Title |
| |
| No 9 (2025) |
Clinical observations of elderly patients with dyspnea in the late post-COVID-19 period |
Abstract
PDF (Rus)
|
|
V. A. Sergeeva, I. V. Chelysheva, M. A. Kutina, F. I. Dzhamaludinova, E. V. Lipchanskaya |
| |
| No 9 (2025) |
The dynamics of respiratory changes on the background of inhalation treatment with tauractant in patients in the post-covid period |
Abstract
PDF (Rus)
|
|
O. O. Voronkova, N. A. Nikolaeva, G. B. Abdullaeva, O. E. Buyanova, E. F. Rogova, Yu. N. Belenkov |
| |
| No 9 (2025) |
Non-invasive ventilation in acute respiratory failure in patients with coronavirus infection at the pre-resuscitation stage |
Abstract
PDF (Rus)
|
|
Z. M. Merzhoeva, A. I. Yaroshetskiy, N. A. Tsareva, N. V. Trushenko, G. S. Nuralieva, V. V. Gaynitdinova, S. N. Avdeev |
| |
| No 20 (2024) |
The role of pulmonary surfactant in the pathogenesis of bronchopulmonary diseases and the prospects of surfactant therapy in COVID-19 |
Abstract
PDF (Rus)
|
|
I. V. Bliznova, L. N. Tolmacheva, M. S. Danilova, R. A. Bontsevich |
| |
| No 20 (2024) |
Prediction of restrictive ventilation disorders after COVID-19 |
Abstract
PDF (Rus)
|
|
O. I. Savushkina, E. S. Muravyeva, S. N. Avdeev, A. A. Zaitsev, G. N. Nekludova, E. V. Kryukov |
| |
| No 20 (2024) |
The use of a heated helium-oxygen mixture in patients with severe COVID-19 and ARDS against the background of standard therapy and noninvasive ventilation |
Abstract
PDF (Rus)
|
|
G. S. Nuralieva, A. E. Shmidt, A. I. Yaroshetskiy, G. V. Nekludova, V. V. Gaynitdinova, N. A. Tsareva, Z. M. Merzhoeva, S. Yu. Chikina, N. V. Trushenko, I. S. Avdeev, S. N. Avdeev |
| |
| No 20 (2024) |
Dyspnea in COVID-associated lung disease |
Abstract
PDF (Rus)
|
|
D. V. Fan, G. V. Nekludova, S. N. Avdeev |
| |
| No 9 (2024) |
Fatigue syndrome after COVID-19 infection: results of personal observations |
Abstract
PDF (Rus)
|
|
P. E. Kolesnikov, A. A. Vizel, A. R. Abashev, L. V. Davydova |
| |
| No 9 (2024) |
The effect of levilimab on the clinical presentations and changes in inflammatory biomarkers in outpatients with mild to moderate COVID-19 |
Abstract
PDF (Rus)
|
|
T. N. Nizhenko, E. V. Shikh, Zh. M. Sizova, V. N. Drozdov, N. I. Lapidus, A. E. Pakhomova |
| |
| No 9 (2024) |
Incidence of coronavirus disease (COVID-19) in patients with different degrees of chronic rhinosinusitis with nasal polyps |
Abstract
PDF (Rus)
|
|
E. V. Lyubimova, E. L. Savlevich, A. V. Zurochka, E. S. Mitrofanova, O. M. Kurbacheva |
| |
| No 9 (2024) |
Silent hypoxemia – A specific sign of COVID-associated pneumonia? |
Abstract
PDF (Rus)
|
|
G. V. Nekludova, D. V. Fan, N. V. Trushenko, G. S. Nuralieva, Z. G. Berikkhanov, S. N. Avdeev |
| |
| No 9 (2024) |
6-minute walk test in patients hospitalized with COVID-19 |
Abstract
PDF (Rus)
|
|
T. V. Kanaeva, N. A. Karoli |
| |
| No 5 (2024) |
Clinical efficacy of various regimens of systemic glucocorticoids therapy in COVID-19 patients |
Abstract
PDF (Rus)
|
|
N. I. Voloshin, V. V. Salukhov, A. A. Minakov, M. O. Prokhorova, T. A. Belyakova, V. V. Kochukova |
| |
| No 5 (2024) |
Applying vibroacoustic therapy in the treatment of patients with COVID-associated pneumonia |
Abstract
PDF (Rus)
|
|
G. S. Nuralieva, A. S. Shmidt, G. V. Nekludova, V. V. Gaynitdinova, N. A. Tsareva, Z. M. Merzhoeva, S. Yu. Chikina, N. V. Trushenko, Z. G. Berikkhanov, O. A. Suvorova, F. T. Kurkieva, I. S. Avdeev, A. A. Bolotskaia, S. N. Avdeev |
| |
| No 9 (2024) |
Surfactant protein D as a marker of persistent impairment of the lungs diffusion capacity in the long-term period in patients who had suffered from severe COVID-19 |
Abstract
PDF (Rus)
|
|
G. B. Abdullaeva, M. V. Kozhevnikova, D. S. Valiulina, Yu. N. Belenkov |
| |
| No 9 (2024) |
Clinical observation of the long-term course of COVID-19 infection in a patient with an immunodeficiency condition |
Abstract
PDF (Rus)
|
|
N. A. Nikolaeva, O. O. Voronkova, S. M. Glukhova, P. A. Nagornaya, E. F. Rogova, A. S. Lishuta, M. V. Kozhevnikova, Yu. N. Belenkov |
| |
| No 20 (2023) |
Difficulties in diagnosing complications of COVID-19: description of a clinical case |
Abstract
PDF (Rus)
|
|
E. V. Loshkova, M. V. Rebrienko, I. V. Doroshenko, T. S. Lyulka, A. V. Budkin, Yu. S. Rafikova, E. I. Kondratyeva, A. I. Khavkin, N. D. Odinaeva, A. L. Solnyshko, Е. V. Golikova |
| |
| No 20 (2023) |
Possible perspectives for using phytoadaptogens in post-COVID period |
Abstract
PDF (Rus)
|
|
M. V. Sankova, D. F. Mesitskaya, D. A. Andreev, A. V. Sankov |
| |
| No 20 (2023) |
Characteristics of patients with sarcoidosis who referred to a pulmonologist during the COVID-19 pandemic |
Abstract
PDF (Rus)
|
|
A. A. Vizel, I. Yu. Vizel, G. R. Shakirova, L. A. Vizel |
| |
| No 20 (2023) |
Hypoxemia without dyspnea in COVID-19 |
Abstract
PDF (Rus)
|
|
D. V. Fan, G. V. Nekludova, Z. G.-M. Berikkhanov, S. N. Avdeev |
| |
| No 16 (2023) |
Cardiovascular complications in the context of COVID-19: arrhythmias |
Abstract
PDF (Rus)
|
|
A. S. Zmitrukevich, A. E. Mamedova, E. V. Reznik |
| |
| No 13 (2023) |
Skeletal and muscular manifestations of post-COVID syndrome: literature review |
Abstract
PDF (Rus)
|
|
K. M. Minigalina, Kh. Kh. Gantseva, L. D. Sadretdinova, V. B. Golubyatnikov, K. E. Akhiiarova, A. V. Tyurin |
| |
| No 13 (2023) |
Epidemiological analysis of systemic mycoses in COVID-19 |
Abstract
PDF (Rus)
|
|
A. V. Martynova, O. S. Pavlova, E. P. Yusupova |
| |
| No 6 (2023) |
Glucocorticoids in the combination therapy of COVID-19 |
Abstract
PDF (Rus)
|
|
V. V. Skvortsov, A. V. Tumarenko, E. A. Malyakina, G. I. Maljakin |
| |
| No 6 (2023) |
Possibilities of personalized pharmacotherapy and medical rehabilitation of patients with long COVID from the perspective of clinical metabolomics |
Abstract
PDF (Rus)
|
|
I. V. Kukes, V. G. Lim, K. A. Ivantsov, E. Yu. Solovyeva, L. P. Sokolova, I. R. Gilmutdinova, P. B. Glagovskiy, M. S. Ptitsyn |
| |
| No 4 (2023) |
Post-COVID syndrome: clinical presentations and therapeutic approaches |
Abstract
PDF (Rus)
|
|
S. Yu. Chikina |
| |
| No 4 (2023) |
Antibacterial therapy: questions posed by COVID-19 and real clinical practice |
Abstract
PDF (Rus)
|
|
A. A. Vizel, I. Yu. Vizel |
| |
| No 4 (2023) |
Analysis of treatment approaches and the efficiency of application of a decision support program in polyclinic practice during the covid-pandemic period |
Abstract
PDF (Rus)
|
|
R. A. Bontsevich, V. K. Kotlyarova, O. A. Bukach, A. V. Gubarev, D. G. Dubonosova, I. G. Rostovceva |
| |
| No 4 (2023) |
The use of inhaled tauractant therapy in the subacute period of COVID-19 |
Abstract
PDF (Rus)
|
|
O. O. Voronkova, A. A. Starzhevskaia, V. G. Skachek, E. F. Rogova, G. B. Abdullaeva, O. E. Buyanova, M. V. Kozhevnikova, Yu. N. Belenkov |
| |
| No 4 (2023) |
Early distinctive clinical and hematological signs of hemorrhagic fever with renal syndrome and a new coronavirus infection occurring with lung damage |
Abstract
PDF (Rus)
|
|
G. A. Galieva, G. Kh. Mirsaeva, G. A. Mavzyutova, N. N. Mironchuk, L. Kh. Amineva, E. R. Kamaeva, T. N. Lisovskaya, A. R. Mukhetdinov |
| |
| No 4 (2023) |
Experience of using systemic glucocorticoids during reconvalescence of patients after a new coronavirus infection of moderate severity |
Abstract
PDF (Rus)
|
|
Yu. V. Rudakov, A. A. Bogomolov, V. V. Salukhov, M. A. Kharitonov, A. A. Chugunov |
| |
| No 23 (2022) |
Analysis of severity and evaluation of prognosis in elderly patients with bronchial asthma and severe COVID-19 |
Abstract
PDF (Rus)
|
|
V. V. Gaynitdinova, S. N. Avdeev, A. A. Pozdniakova, A. E. Vlasenko, T. Yu. Gneusheva, K. A. Ter-Akopian, D. U. Allaberdina |
| |
| No 23 (2022) |
Features of the pathology of the lymphoid ring of the pharynx in children during the COVID-19 pandemic |
Abstract
PDF (Rus)
|
|
A. V. Andrianov, M. V. Drozdova, Yu. S. Preobrazhenskaya |
| |
| No 23 (2022) |
Hospital readmissions of patients with COVID-19: causes, features, outcomes |
Abstract
PDF (Rus)
|
|
O. N. Potanina, S. A. Ayrapetyan, S. O. Mazurenko, V. V. Strizheletsky, L. S. Palchikova, N. A. Teplyakova, L. G. Ermolaeva, Iu. M. Gomon, N. Yu. Semigolovskii |
| |
| No 23 (2022) |
Evaluation of the association of CES1 (rs2244613) polymorphisms with the safety of remdesivir in hospitalized patients with COVID-19 |
Abstract
PDF (Rus)
|
|
I. I. Temirbulatov, A. V. Kryukov, K. B. Mirzaev, N. P. Denisenko, Sh. P. Abdullaev, A. A. Kachanova, Zh. A. Sozaeva, A. S. Zhiryakova, Yu. V. Shevchuk, V. I. Vechorko, O. V. Averkov, D. A. Sychev |
| |
| No 23 (2022) |
Prospects for studying the role of some essential and toxic trace elements in the pathogenesis of COVID-19 |
Abstract
PDF (Rus)
|
|
O. O. Yanushevich, A. O. Romanov, M. V. Ivkina, A. N. Arkhangelskaia, M. M. Sharipova, M. V. Yakovleva, I. I. Shantyr, M. A. Vlasenko, K. G. Gurevich, O. V. Levchenko, I. V. Maev |
| |
| No 18 (2022) |
Functional and quantitative computed tomographic changes in the bronchopulmonary system in patients who have undergone COVID-19 |
Abstract
PDF (Rus)
|
|
A. V. Cherniak, N. A. Karchevskaya, I. M. Skorobogach, O. V. Leshchinskaya, E. N. Kalmanova, K. A. Zykov, S. S. Petrikov |
| |
| No 18 (2022) |
Correct treatment regimen and inhalation technique are the components of success in bronchial asthma in the era of COVID-19 |
Abstract
PDF (Rus)
|
|
Yu. G. Belotserkovskaya, A. G. Romanovskikh, I. P. Smirnov |
| |
| No 18 (2022) |
Some features of the course of viral pneumonia in obesity |
Abstract
PDF (Rus)
|
|
A. A. Minakov, V. V. Salukhov, M. A. Kharitonov, G. G. Zagorodnikov, N. I. Voloshin |
| |
| No 18 (2022) |
Postcovid syndrome, cardiovascular disorders |
Abstract
PDF (Rus)
|
|
I. N. Redkina, L. A. Suplotova, M. I. Bessonova |
| |
| No 18 (2022) |
Prospects for studying the role of some essential and toxic trace elements in the pathogenesis of COVID-19 |
Abstract
PDF (Rus)
|
|
M. M. Sharipova, A. O. Romanov, M. V. Ivkina, A. N. Arkhangelskaia, K. G. Gurevich |
| |
| No 18 (2022) |
New coronavirus infection (COVID-19) and respiratory diseases / pathological conditions |
Abstract
PDF (Rus)
|
|
D. I. Trukhan |
| |
| No 18 (2022) |
COVID-19 and lung damage in obese patients: results of a prospective study |
Abstract
PDF (Rus)
|
|
A. V. Buchneva, N. V. Chichkova, E. V. Fominykh, N. V. Krupochkina, V. V. Fomin |
| |
| No 15 (2022) |
Nutrition of elderly persons during a new coronavirus infection |
Abstract
PDF (Rus)
|
|
S. A. Solgalova, S. G. Kechedzhieva |
| |
| No 15 (2022) |
Evaluation of the efficacy and safety of remdesivir in hospitalized patients with a new coronavirus infection COVID-19: data from a Russian university clinic |
Abstract
PDF (Rus)
|
|
O. O. Yanushevich, I. V. Maev, N. I. Krikheli, O. V. Levchenko, D. N. Andreev, P. S. Sokolov, A. K. Fomenko, M. K. Devkota, N. G. Andreev, A. V. Zaborovsky, D. I. Shefer |
| |
| No 14 (2022) |
Sleep disorders, cardiovascular symptoms and body weight dynamics in women with post-COVID-19 syndrome |
Abstract
PDF (Rus)
|
|
V. A. Sergeeva, T. E. Lipatova |
| |
| No 14 (2022) |
Рrognostic value of proadrenomedullin in patients with COVID-19 |
Abstract
PDF (Rus)
|
|
A. A. Astapovskii, V. N. Drozdov, E. V. Shikh, N. B. Lazareva, S. Yu. Serebrova |
| |
| No 14 (2022) |
The effect of a new coronavirus infection caused by the SARS-CoV-2 virus on microcirculation in the conjunctiva |
Abstract
PDF (Rus)
|
|
T. N. Safonova, G. V. Zaitseva, N. P. Kintyukhina |
| |
| No 14 (2022) |
Therapy experience in alopecia after COVID-19 |
Abstract
PDF (Rus)
|
|
O. A. Katkhanova, M. V. Golubchenko |
| |
| No 6 (2022) |
Features of the course of COVID-19 in patients with comorbid pathology |
Abstract
PDF (Rus)
|
|
M. M. Sharipova, M. V. Ivkina, A. N. Arkhangelskaia, K. G. Gurevich, I. V. Maev |
| |
| No 6 (2022) |
Prospects for finding means of non-specific prevention of COVID-19 infection |
Abstract
PDF (Rus)
|
|
D. V. Usenko |
| |
| No 4 (2022) |
Possibilities of information systems for prediction of outcomes of new coronavirus infection COVID-19 |
Abstract
PDF (Rus)
|
|
I. V. Demko, E. E. Korchagin, O. A. Cherkashin, N. V. Gordeeva, D. A. Anikin, D. A. Anikina |
| |
| No 4 (2022) |
Factors affecting the content of Ig G-antibodies to S-protein SARS-CoV-2 in the blood of reconvalescents after new coronaviral infection (COVID-19) |
Abstract
PDF (Rus)
PDF (Eng)
|
|
E. V. Kryukov, V. V. Salukhov, B. N. Kotiv, D. V. Ovchinnikov, Yu. V. Andreychuk, D. G. Denisov, A. B. Bogomolov, M. A. Kharitonov, Yu. V. Rudakov, P. S. Sadovnikov, A. A. Chugunov |
| |
| No 4 (2022) |
Surfactant therapy for pneumonia COVID-19 of obstetric patients |
Abstract
PDF (Rus)
|
|
M. V. Shvechkova, I. I. Kukarskaya, A. E. Bautin, T. V. Legalova, R. N. Marchenko, A. S. Shvechkova, E. Yu. Kukarskaya, E. A. Yakovleva |
| |
| No 4 (2022) |
Astenic syndrome in you students with different online-behaviors during the pandemic of new coronavirus infection COVID-19 |
Abstract
PDF (Rus)
|
|
L. S. Evert, N. Yu. Grishkevich, Yu. R. Kostyuchenko, S. S. Seren-ool, S. A. Bakhshieva |
| |
| No 4 (2022) |
Atorvastatin: old friend in the light of novel coronavirus infection’s pandemia |
Abstract
PDF (Rus)
|
|
M. V. Ezhov, T. E. Kolmakova, M. M. Matveeva, I. A. Alekseeva |
| |
| No 21-1 (2021) |
“Long covid” (postcovid syndrome). Mechanism of occurrence, diagnosis and rehabilitation |
Abstract
PDF (Rus)
|
|
En. D. Choi |
| |
| No 21-1 (2021) |
Probiotics: relevant during the coronavirus (COVID-19) infection pandemic? |
Abstract
PDF (Rus)
|
|
M. A. Shevyakov |
| |
| No 16 (2021) |
Optimization of therapy of patients with bronchial asthma in conditions of coronavirus infection |
Abstract
PDF (Rus)
|
|
E. M. Kostina, E. Yu. Trushina, E. A. Orlova |
| |
| No 16 (2021) |
Influenza in the COVID-19 era: principles of modern pharmacotherapy |
Abstract
PDF (Rus)
|
|
N. B. Lazareva |
| |
| No 16 (2021) |
Single-photon emission tomography of the lungs in the diagnosis of coagulopathyin patients in the postcovid period |
Abstract
PDF (Rus)
|
|
V. P. Zolotnitskaya, O. N. Titova, N. A. Kuzubova, A. P. Litvinov |
| |
| No 16 (2021) |
Analysis of the antibiotic consumption on the backdrop of the COVID-19 pandemic: hospital level |
Abstract
PDF (Rus)
|
|
K. I. Karnoukh, N. B. Lazareva |
| |
| No 16 (2021) |
Coronavirus pneumonia in kidney transplant recipients: current evidence from own clinical experience |
Abstract
PDF (Rus)
|
|
I. V. Lekareva, A. L. Emelianova, E. V. Kalinina, A. R. Babaeva, E. V. Scherbinina |
| |
| No 16 (2021) |
Viral pneumonia: a new look at an old problem (review) |
Abstract
PDF (Rus)
|
|
M. A. Kharitonov, V. V. Salukhov, E. V. Kryukov, M. B. Patsenko, Yu. V. Rudakov, A. B. Bogomolov, V. V. Ivanov, A. A. Minakov |
| |
| No 16 (2021) |
Clinical case of nebulized surfactant therapy for severe COVID-19-associated pneumonia at the 2nd stage of rehabilitation treatment |
Abstract
PDF (Rus)
|
|
I. Yu. Stulikova, A. V. Tsvetkova, E. S. Koneva, T. V. Shapovalenko |
| |
| No 16 (2021) |
The effectiveness of combination of 7% hypertonic saline and 0.1% natrii hyaluronas in patients with chronic obstructive pulmonary disease who have suffered a new coronavirus infection |
Abstract
PDF (Rus)
|
|
O. N. Titova, N. A. Kuzubova, D. B. Skliarova, A. L. Aleksandrov, N. V. Egorova |
| |
| No 17 (2020) |
Antagonism between pneumococcal vaccines and COVID-19 |
Abstract
PDF (Rus)
|
|
A. M. Kostinov, M. P. Kostinov, C. V. Mashilov |
| |
| No 17 (2020) |
Inhaled surfactant in patients with covid-19 who took high-flow oxygen: the results of a retrospective analysis |
Abstract
PDF (Rus)
|
|
A. V. Averyanov, T. V. Klypa, O. I. Balionis, M. V. Bychinin, A. V. Cherniak, A. V. Troitskiy, E. V. Trifonova |
| |
| No 17 (2020) |
Predicting the duration of inpatient treatment for COVID-19 patients |
Abstract
PDF (Rus)
|
|
V. V. Tsvetkov, I. I. Tokin, D. A. Lioznov, E. V. Venev, A. N. Kulikov |
| |
| 1 - 69 of 69 Items |
|
